0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.87.25. Please contact the publisher to request reinstatement.
Clinicopathologic Reports, Case Reports, and Small Case Series |

Idiopathic Juxtafoveal Telangiectasis in Association With Celiac Sprue FREE

Henry C. Lee, MD; Mimi Liu, MD; Allen C. Ho, MD
[+] Author Affiliations

Section Editor: W. Richard Green, MD


Arch Ophthalmol. 2004;122(3):411-413. doi:10.1001/archopht.122.3.411.
Text Size: A A A
Published online

Idiopathic juxtafoveal telangiectasis (IJFT) is a condition of uncertainetiology that is characterized by retinal telangiectasias, superficial retinalcrystalline deposits, right-angle venules, and intraretinal pigment plaques.It is capable of causing visual loss in otherwise healthy patients, and treatmentremains controversial. It was first described by Reese in 19561 andhas subsequently been divided into 3 groups by Gass and Blodi.2

We describe a patient with IJFT and celiac sprue. To the best of ourknowledge, this is the first reported case showing a potential associationbetween these 2 conditions.

A 53-year-old woman with biopsy-proved celiac sprue reported a 10-yearhistory of blurred central vision in both eyes. Her medical history was otherwiseunremarkable. She denied a history of diabetes and had a normal blood glucoselevel, but she declined a formal glucose tolerance test. Her medical regimenincluded a multivitamin, hormone replacement therapy (estrogen-medroxyprogesterone),and a gluten-free diet. Her family history included no relatives with similarvisual loss.

Best-corrected visual acuity was 20/60 OD and 20/40 OS. Clinical examinationshowed clear media and symmetric optic discs. Macular edema and a perifovealgray macular sheen were noted with apparent foveal thinning; no lipid or hemorrhagewas present. A right-angle venule was noted in the temporal right macula (Figure 1).

Place holder to copy figure label and caption
Figure 1.

Color fundus photographs of thepatient's right (A) and left (B) eyes showing the perifoveal gray macularsheen. A right-angle venule was noted in the temporal right macula.

Graphic Jump Location

Fluorescein angiography showed intraretinal telangiectasia with leakagefor 340° in the right eye and nearly 360° surrounding the fovea inthe left eye (Figure 2). Opticalcoherence tomography showed foveal thinning in both eyes with mild macularthickening (Figure 3).

Place holder to copy figure label and caption
Figure 2.

Fluorescein angiograms showingearly and late frames of the right (A and B) and left (C and D) eyes. Notethe perifoveal intraretinal telangiectasias with leakage in both eyes.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Optical coherence tomograms ofthe right (A) and left (B) eyes showing bilateral thinning of the fovea withmild macular thickening.

Graphic Jump Location

Celiac sprue is characterized by malabsorption due to injury to theintestinal mucosa after ingestion of wheat gluten or related proteins. Thereis both clinical and histologic improvement on a strict gluten-free diet,and relapse occurs when dietary gluten is reintroduced.3 Untilrecently, celiac sprue was thought to be an uncommon condition in the UnitedStates, with an estimated prevalence of 1 in 3000. However, greater awarenessof its manifestations and the advent of more accurate serologic tests haveled to the realization that celiac sprue is relatively common, affecting approximately1 of every 120 to 300 persons in North America.4

Celiac sprue is caused by an inappropriate T cell–mediated immuneresponse against ingested gluten, causing damage to the intestinal mucosa,and the classic histologic finding of absent villi and hyperplastic crypts.There is a strong genetic component, with more than 95% of patients expressingthe HLA-DQ2 heterodimer.5

Classically, celiac sprue is seen in infants with impaired growth andabdominal distention. The onset of symptoms is gradual, following the introductionof cereals into the diet. The condition is also increasingly being diagnosedin adults, in whom symptoms include diarrhea, flatulence, weight loss, andlactose intolerance. However, many patients have atypical symptoms or noneat all.

To our knowledge, this case represents the first reported associationbetween celiac sprue and IJFT. Although the concurrence of the 2 disordersmay be coincidental, it may represent a previously unrecognized association,due to the historic underdiagnosis of celiac sprue by the medical community.

The underlying pathophysiologic characteristics of IJFT are still largelyunknown. Green and associates6 studiedthe histologic features of a patient with group 2A IJFT and found thickenedretinal capillaries with narrowed lumens. This was theorized to be a resultof endothelial degeneration and regeneration, with increased basement membraneproduction, and secondary pericyte loss. Gass and Blodi2 suggestedthat these might cause decreased metabolic exchange and increased endothelialpermeability, thus leading to chronic nutritional damage to the juxtafovealretinal cells.

Likewise, some studies suggest that the primary defect in celiac spruemay be an abnormally increased permeability of the intestinal epithelium.A preexisting permeability defect may trigger the expression of celiac sprueby allowing ingested gluten to cross the epithelial barrier and incite a pathologicimmune reaction in genetically susceptible individuals.7

Thus, one possible explanation for an association between IJFT and celiacsprue is an underlying systemic permeability defect that is responsible forboth increased gluten hypersensitivity in the gut and endothelial decompensationin the retina. As more patients with celiac sprue are identified, future investigationsshould disclose whether there is a true causal association between celiacsprue and IJFT.

Corresponding author: Allen C. Ho, MD, Wills Eye Hospital, 840 WalnutSt, Philadelphia, PA 19107 (e-mail: acho@att.net)

Reese  AB Telangiectasis of the retina and Coats' disease. Am J Ophthalmol. 1956;421- 8
PubMed
Gass  JDMBlodi  BA Idiopathic juxtafoveolar retinal telangiectasis: update of classificationand follow-up study. Ophthalmology. 1993;1001536- 1546
PubMed
Trier  JS Celiac sprue. N Engl J Med. 1991;3251709- 1719
PubMed
Not  THorvath  KHill  ID  et al.  Celiac disease risk in the USA: high prevalence of antiendomysium antibodiesin healthy blood donors. Scand J Gastroenterol. 1998;33494- 498
PubMed
Farrell  RJKelly  CP Celiac sprue. N Engl J Med. 2002;346180- 188
PubMed
Green  WRQuigley  HADe la Cruz  ZCohen  B Parafoveal retinal telangiectasis: light and electron microscopy studies. Trans Ophthalmol Soc U K. 1980;100162- 170
PubMed
DeMeo  MTMutlu  EAKeshavarzian  ATobin  MC Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34385- 396
PubMed

Figures

Place holder to copy figure label and caption
Figure 1.

Color fundus photographs of thepatient's right (A) and left (B) eyes showing the perifoveal gray macularsheen. A right-angle venule was noted in the temporal right macula.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Fluorescein angiograms showingearly and late frames of the right (A and B) and left (C and D) eyes. Notethe perifoveal intraretinal telangiectasias with leakage in both eyes.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Optical coherence tomograms ofthe right (A) and left (B) eyes showing bilateral thinning of the fovea withmild macular thickening.

Graphic Jump Location

Tables

References

Reese  AB Telangiectasis of the retina and Coats' disease. Am J Ophthalmol. 1956;421- 8
PubMed
Gass  JDMBlodi  BA Idiopathic juxtafoveolar retinal telangiectasis: update of classificationand follow-up study. Ophthalmology. 1993;1001536- 1546
PubMed
Trier  JS Celiac sprue. N Engl J Med. 1991;3251709- 1719
PubMed
Not  THorvath  KHill  ID  et al.  Celiac disease risk in the USA: high prevalence of antiendomysium antibodiesin healthy blood donors. Scand J Gastroenterol. 1998;33494- 498
PubMed
Farrell  RJKelly  CP Celiac sprue. N Engl J Med. 2002;346180- 188
PubMed
Green  WRQuigley  HADe la Cruz  ZCohen  B Parafoveal retinal telangiectasis: light and electron microscopy studies. Trans Ophthalmol Soc U K. 1980;100162- 170
PubMed
DeMeo  MTMutlu  EAKeshavarzian  ATobin  MC Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34385- 396
PubMed

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles